Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.48 -0.01 (-2.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Non Operating Interest Expenses (2023)

Updated

Pasithea Therapeutics' Non Operating Interest Expenses was -$117,191 in Q2 2023.

Analysis

Pasithea Therapeutics (KTTA) Non Operating Interest Expenses (2023) Analysis & Trends

For FY2022, Non Operating Interest Expenses at Pasithea Therapeutics came in at $102.00, down 79.9% from FY2021.

  • In earlier years, Non Operating Interest Expenses was $508.00 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -117,191.00
Mar 31, 2023 6,388.00
API Access

Pasithea Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=KTTA&period=max&api_key=YOUR_API_KEY